** DIABETES MANAGEMENT CERTIFICATE PROGRAM

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached.

Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.

Article #1 – ADA Indications for Statins in Diabetes – Roy Eldor, MD

Article #2 - Guideline Updates: What’s new in the ADA and AACE/ ACE Guidelines – Doug Jones, MD

Objectives

List the differences between the 2019 ADA and AACE national guidelines for the management of type 1 and type 2 diabetes and how they differ in approach from previous guidelines
Explain the latest recommendation for the management of type 2 diabetes patients with renal failure
Describe the latest recommendations for the management of type 2 diabetes patients with cardiovascular disease
Describe the latest recommendations for the management of type 2 diabetes patients with hemoglobin A1C greater than 9%.

Speaker(s)/Author(s)

Ola Odugbesan, MD, MRCP, FACE, MD, MRCP, FACE

Activity Number

0010-0000-21-026-H01-P

Release Date: Mar 4, 2021

Credit Expiration Date: Mar 4, 2024

CE Hours

2.00

Registration Closed

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached.

Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.

Article #1 - Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline - Guillermo E. Umpierrez,

Article #2 - Outpatient Management of Pediatric Type 1 Diabetes- Joni K Beck, Pharm.D.

Article #3 - Approaches to rapid-acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets – Alexandra Migdal

Article #4 - Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update from the American College of Physicians – Amir Qaseem, MD, PhD, MHA

Article #5 - An update on SGLT 2 inhibitors for the treatment of Diabetes Mellitus – Daniel S. Hsia

Objectives

Recognize diabetes medications that have been demonstrated to have favorable effects on ASCVD risk
Describe individualized T2DM therapy based on a clinical understanding of the features of oral and injectable antidiabetic medications and patient-specific needs and preferences.
List strategies to overcome barriers to insulin intensification in T2DM, including clinical inertia and the risk of hypoglycemia.
Describe patient education and patient-prescriber communication strategies to aid patients in overcoming concerns about insulin intensification and fear of injections, thus increasing patient adherence to therapy and improving clinical outcomes

Speaker(s)/Author(s)

Kendra Lewis, Pharm.D., BC-Adm, CDE, PharmD

Activity Number

0010-0000-21-027-H01-P

Release Date: Mar 4, 2021

Credit Expiration Date: Mar 4, 2024

CE Hours

2.00

Registration Closed

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached.

Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.

Article #1 - Suitable Use of Injectable Agents to Overcome Hypoglycemic Risk – Willy M. Valencia.

Article #2. Type 2 Diabetes Mellitus: Outpatient insulin Management - Amanda Howard-Thompson, PharmD

Article #3. Management of hypoglycemia in older adults with type 2 diabetes – Jeffery Freeman.

Objectives

List the approaches to initiating, switching, and adjusting basal and prandial insulins for improved glycemic control.
Describe physician and patient-directed insulin titration strategies used in clinical practice, which are different from those used in type 2 diabetes.
Describe practical considerations for initiating therapies other than insulin in type 1 diabetes
List the information that continuous glucose monitoring technology provides.

Speaker(s)/Author(s)

Jennifer Elliott, Pharm.D., CDE, BCADP

Activity Number

0010-0000-21-028-H01-P

Release Date: Mar 4, 2021

Credit Expiration Date: Mar 4, 2024

CE Hours

2.00

Registration Closed

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached.

Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.

Article #1. Inappropriate use of Medication by Elderly, Polymedicated, or Multipathological Patients with Chronic Diseases – Virtudes Perez-Jover

Article #2 – The Unmet Challenge of Medication Nonadherence – Fred Kleinsinger MD

Objectives

List the emerging adherence quality drivers and their relevance in your healthcare setting
List the five factors that influence patient medication adherence
Explain the importance of communication between health professionals and their patients and caregivers
List simple strategies, techniques, and resources to support patient engagement

Speaker(s)/Author(s)

Lenore T. Coleman, Pharm.D., CDE
President and Founder, Healing our Village, Inc.

Activity Number

0010-0000-21-034-H05-P

Release Date: Mar 4, 2021

Credit Expiration Date: Mar 4, 2024

CE Hours

2.00

Registration Closed

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached.

Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.

Article #1. Nutritional Strategies for Prevention and Management of Diabetes: Consensus and Uncertainties – Judith Wylie-Rosetti

Article #2. Paradigm Shifts in Nutrition Therapy for Type 2 Diabetes- Nutrition Therapy for diabetes- Satoru Yamada

Objectives

Explain the nutrient recommendations for the various classifications of diabetes, listing carbohydrate, fiber, protein, and fat amounts
Explain the differences between meal planning, energy, and nutrient requirements for type 1 and type 2 diabetes
Define the glycemic response, and explain how this concept is applied to the nutritional control of diabetes
List three sugar substitutes presently used, and discuss their positive and negative features
List several meal-planning approaches explaining the benefits and drawbacks of each
Identify the problems and guidelines for use of alcohol, eating out, snacking, hypoglycemic episodes, and sick day management

Speaker(s)/Author(s)

Lamura Poore, RD

Activity Number

0010-0000-21-029-H01-P

Release Date: Mar 4, 2021

Credit Expiration Date: Mar 4, 2024

CE Hours

2.00

Registration Closed

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached.

Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.

Article #1. Current perspectives on cardiovascular outcome trials in diabetes – Oliver Schnell

Article #2. Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials – Deborah Hinnen

Article #3. Report from the 4^th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease and EASD Study Group – Oliver Schnell

Objectives

List the major diabetes outcomes trials (ACCORD, ADVANCE, UKPDS, VADT, Look Ahead) and their key findings
Explain the excess risk of cardiovascular disease (CVD) associated with diabetes mellitus compared to nondiabetic patients.
Describe the evidence that the use of SGLT2 inhibitors and GLP-1 agonists in diabetic patients is associated with the reduction of CVD.
Recognize practical implications of recent findings in EMPA-REG and LEADER trials on current treatment algorithms and future clinical studies

Speaker(s)/Author(s)

James R. Gavin III MD, PhD

Activity Number

0010-0000-21-030-H01-P

Release Date: Mar 4, 2021

Credit Expiration Date: Mar 4, 2024

CE Hours

2.00

Registration Closed

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached.

Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.

Article #1. Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus – Gayatri Lessey

Article #2. Management of diabetic dyslipidemia: An Update – Iswarlal Jialal, MD, PhD

Article #3. From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research – Radia Marium Modhumi Khan

Objectives

Describe strategies to optimize the impact of lifestyle interventions in the treatment of diabetes and related conditions
List evidence-based treatment strategies on the management and treatment of cardiovascular disease including hypertension, coronary artery disease, and heart failure
Identify evidence-based treatment strategies for the management of renal disease and renal disease complications.

Speaker(s)/Author(s)

Lenore T. Coleman, Pharm.D., CDE
President and Founder, Healing our Village, Inc.

Activity Number

0010-0000-21-031-H01-P

Release Date: Mar 4, 2021

Credit Expiration Date: Mar 4, 2024

CE Hours

2.00

Registration Closed

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached.

Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.

Article #1. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital – Guillermo E. Umpierrez MD

Article #2. Impact of technology-based interventions for children and young people with type 1 diabetes on key diabetes self-management behaviors and prerequisites: a systematic review – Emily C.L. Knox

Article #3. Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial - S. N. Parsons

Objectives

Describe how self-monitoring of blood glucose can be used most effectively in patients with type 2 diabetes not taking insulin.
Identify when to use CGM data with insulin pump dosing information.
Recognize how to integrate CGM data with insulin pump dosing information.
Explain how to incorporate mobile applications into diabetes practice.

Speaker(s)/Author(s)

Lenore T. Coleman, Pharm.D., CDE
President and Founder, Healing our Village, Inc.

Activity Number

0010-0000-21-032-H01-P

Release Date: Mar 4, 2021

Credit Expiration Date: Mar 4, 2024

CE Hours

2.00

Registration Closed

Each of these CE programs has two sections. To claim the 2 CEs, participants must attend both the live recorded presentation and complete the home study readings. The ppt and the pdf of the reading articles are attached.

Participants have until March 1st, 2024 to earn the 2.0 contact hours of ACPE approved Continuing Pharmacy Education (CPE) credit for this activity by full session attendance/participation AND successful completion of the online activity evaluation and post-assessment test. After March 1st, 2024 the program will be CLOSED, and NO CE credit will be available for this program. Credits will be transferred electronically to the CPE Monitor System.

Article #1 – Culturally tailoring patient education and communication skills training to empower African Americans with diabetes – Monica E. Peek, MD, MPH

Objectives

List the various clinical conditions in which we see disparities in health
List the various social and environmental inequities that lead to poor health outcomes
Identify the barriers to health literacy.
Explain the strategies and techniques to employ cross-cultural communication
Describe an understanding of cultural competency using specific examples

Speaker(s)/Author(s)

Lenore T. Coleman, Pharm.D., CDE
President and Founder, Healing our Village, Inc.

Activity Number

0010-0000-21-033-H01-P

Release Date: Mar 4, 2021

Credit Expiration Date: Mar 4, 2024

CE Hours

2.00

Registration Closed

Fee

CE Hours

CE Units

Activity Type

Target Audience(s)

Accreditation(s)